小児ワクチンのアメリカ市場

◆英語タイトル:Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 - 2025
◆商品コード:DPI80506
◆発行会社(リサーチ会社):DPI Research
◆発行日:2018年4月19日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:米国
◆販売価格オプション(消費税別)
Single UserUSD850 ⇒換算¥96,050見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD1,450 ⇒換算¥163,850見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDPI Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
DPI Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development.
“Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025”provides a unique tool for evaluating the market, highlighting opportunities, supporting strategic and tactical decision–making. This report recognizes that in this rapidly–evolving and competitive environment, up–to–date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on United States pediatric vaccines market. The report also provides clear insight into current and future developments of the United States pediatric vaccines market. Further more, this report provides a deep and thorough evaluation of the top 10 pediatric Vaccines by disease indication. On the basis of disease indication, the top 10 pediatric Vaccines provide an in-depth analysis of doses administered number of children being vaccinated and market size. The research includes historic data from 2010 to 2017 and forecasts until 2025.

The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccines market.

The report concludes with the profiles of major players in the United States pediatric vaccines market. The key market players are evaluated on various parameters such as company overview, pediatric vaccines portfolios and latest development & trends of the pediatric vaccines market.

The Major Companies dominating this Market for its Products, Services and Continuous Product Developments are:

• Sanofi Pasteur
• GlaxoSmithKline(GSK)
• Merck & Co.
• Pfizer Inc
• Grifols

Major Pediatric Vaccines (Disease Indication) Covered Under This Report are:

• Diphtheria, Tetanus & Pertussis (DTap)
• Hepatitis A
• Varicella/Chicken Pox
• Pneumococcal
• Haemophilus Influenzae Type B (HIB)
• Polio
• Rotavirus
• Hepatitis B
• Influenza Pediatric
• Measles, Mumps & Rubella (MMR)

The Latest Industry Data Included in this Report:

• United States Pediatric Vaccines Market Size & Analysis ,2010 – 2025
• United States Pediatric Vaccines Market Share and Y–o–Y Growth (%),2010 – 2025
• United States Pediatric Vaccines Market by Disease Indication ,2010 – 2025
• 10 Pediatric Vaccines Doses Administered (Volume),2010 – 2025
• Number of Children Being Vaccinated (Volume)2010 – 2025
• 10 Pediatric Vaccines Market Size and Forecast(Value),2010 – 2025
• Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Product Portfolios and Latest Recent Development and Trends

The following key questions have been addressed in the report:

• What is the size of the United States pediatric vaccines market during 2010 -2025?
• How will each segment of the United States pediatric vaccines market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2025?
• Which major pediatric vaccines provides highest market share?
• How much number of children being vaccinated during 2010-2025?
• How are the overall market and segments types growing?
• What are the major market drivers and inhibitors in the United States pediatric vaccines market?
• Who are the key players in the United States pediatric vaccines market and what are their contributions?

【レポートの目次】

1. Executive Summary

2. Market Size & Analysis: United States Pediatric Vaccines (2010 – 2025)

3. United States Pediatric Vaccines Market Share and Y–o–Y Growth (%)

4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors

5. United States Pediatric Vaccines Market – By Disease Indication (2010 – 2025)
5.1 Diphtheria, Tetanus & Pertussis (DTap)
5.1.1 Doses Administered (Volume)
5.1.2 Number of Children Being Vaccinated (Volume)
5.1.3 Market Size and Forecast(Value)
5.2 Hepatitis A
5.2.1 Doses Administered(Volume)
5.2.2 Number of Children Being Vaccinated(Volume)
5.2.3 Market Size and Forecast(Value)
5.3 Varicella / Chicken Pox
5.3.1 Doses Administered(Volume)
5.3.2 Number of Children Being Vaccinated(Volume)
5.3.3 Market Size and Forecast(Value)
5.4 Pneumococcal
5.4.1 Doses Administered(Volume)
5.4.2 Number of Children Being Vaccinated(Volume)
5.4.3 Market Size and Forecast(Value)
5.5 Haemophilus Influenzae Type B (HIB)
5.5.1 Doses Administered(Volume)
5.5.2 Number of Children Being Vaccinated(Volume)
5.5.3 Market Size and Forecast(Value)
5.6 Polio
5.6.1 Doses Administered(Volume)
5.6.2 Number of Children Being Vaccinated(Volume)
5.6.3 Market Size and Forecast(Value)
5.7 Rotavirus
5.7.1 Doses Administered(Volume)
5.7.2 Number of Children Being Vaccinated(Volume)
5.7.3 Market Size and Forecast(Value)
5.8 Hepatitis B
5.8.1 Doses Administered(Volume)
5.8.2 Number of Children Being Vaccinated(Volume)
5.8.3 Market Size and Forecast(Value)
5.9 Influenza Pediatric
5.9.1 Doses Administered(Volume)
5.9.2 Number of Children Being Vaccinated(Volume)
5.9.3 Market Size and Forecast(Value)
5.10 Measles, Mumps & Rubella (MMR)
5.10.1 Doses Administered(Volume)
5.10.2 Number of Children Being Vaccinated(Volume)
5.10.3 Market Size and Forecast(Value)

6. Key Companies Analysis
6.1 Sanofi Pasteur
6.1.1 Business Overview
6.1.2 Pediatric Vaccines Portfolio
6.1.3 Pedaitric Vaccines – Latest Development & Trends
6.2 GlaxoSmithKline (GSK)
6.2.1 Business Overview
6.2.2 Pediatric Vaccines Portfolio
6.2.3 Pediatric Vaccines – Latest Development & Trends
6.3 Merck & Co
6.3.1 Business Overview
6.3.2 Pediatric Vaccines Portfolio
6.3.3 Pediatric Vaccines – Latest Development & Trends
6.4 Pfizer Inc
6.4.1 Business Overview
6.4.2 Pediatric Vaccines Portfolios
6.4.3 Pediatric Vaccines – Latest Development & Trends
6.5 Grifols
6.5.1 Business Overview
6.5.2 Pediatric Vaccines Portfolio
6.5.3 Pediatric Vaccines – Latest Development & Trends

Table 3–1: United States Pediatric Vaccines Market Share (Percent), 2010 – 2017
Table 3–2: United States Pediatric Vaccines Market Share Forecast (Percent), 2018 – 2025



Figure 2–1: United States Pediatric Vaccines Market (Million US$), 2010 – 2017
Figure 2–2: United States Pediatric Vaccines Market Forecast (Million US$), 2018 – 2025
Figure 5–1: DTap Vaccines Doses Administered (in Million), 2010 – 2017
Figure 5–2: DTap Vaccines Doses Administered Forecast (in Million), 2018 – 2025
Figure 5–3: Number of Children Being Vaccinated with DTap Vaccines (in Million), 2010 – 2017
Figure 5–4: Number of Children Being Vaccinated with DTap Vaccines Forecast (in Million), 2018 –2025
Figure 5–5: DTap Vaccines Market Value (in Million US$), 2010 – 2017
Figure 5–6: DTap Vaccines Market Value Forecast (in Million US$), 2018 – 2025
Figure 5–7: Hepatitis A Vaccines Doses Administered (in Million), 2010 – 2017
Figure 5–8: Hepatitis A Vaccines Doses Administered Forecast (in Million), 2018 – 2025
Figure 5–9: Number of Children Being Vaccinated with Hepatitis A Vaccines (in Million),2010 – 2017
Figure 5–10: Number of Children Being Vaccinated with Hepatitis A Vaccines Forecast (in Million),2018 – 2025
Figure 5–11: Hepatitis A Vaccines Market Value (in Million US$), 2010 – 2017
Figure 5–12: Hepatitis A Vaccines Market Value Forecast (in Million US$), 2018 – 2025
Figure 5–13: Varicella Vaccines Doses Administered (in Million), 2010 – 2017
Figure 5–14: Varicella Vaccines Doses Administered Forecast (in Million), 2018 – 2025
Figure 5–15: Number of Children Being Vaccinated with Varicella Vaccines (in Million),2010 – 2017
Figure 5–16: Number of Children Being Vaccinated with Varicella Vaccines Forecast (in Million),2018 – 2025
Figure 5–17: Varicella Vaccines Market Value (in Million US$), 2010 – 2017
Figure 5–18: Varicella Vaccines Market Value Forecast (in Million US$), 2018 – 2025
Figure 5–19: Pneumococcal Vaccines Doses Administered (in Million), 2010 – 2017
Figure 5–20: Pneumococcal Vaccines Doses Administered Forecast (in Million), 2018 – 2025
Figure 5–21: Number of Children Being Vaccinated with Pneumococcal Vaccines (in Million),2010 – 2017
Figure 5–22: Number of Children Being Vaccinated with Pneumococcal Vaccines Forecast (in Million),2018 – 2025
Figure 5–23: Pneumococcal Vaccines Market Value (in Million US$), 2010 – 2017
Figure 5–24: Pneumococcal Vaccines Market Value Forecast (in Million US$), 2018 – 2025
Figure 5–25: HIB Vaccines Doses Administered (in Million), 2010 – 2017
Figure 5–26: HIB Vaccines Doses Administered Forecast (in Million), 2018 – 2025
Figure 5–27: Number of Children Being Vaccinated with HIB Vaccines (in Million),2010 – 2017
Figure 5–28: Number of Children Being Vaccinated with HIB Vaccines Forecast (in Million),2018 – 2025
Figure 5–29: HIB Vaccines Market Value (in Million US$), 2010 – 2017
Figure 5–30: HIB Vaccines Market Value Forecast (in Million US$), 2018 – 2025
Figure 5–31: Polio Vaccines Doses Administered (in Million), 2010 – 2017
Figure 5–32: Polio Vaccines Doses Administered Forecast (in Million), 2018 – 2025
Figure 5–33: Number of Children Being Vaccinated with Polio Vaccines (in Million),2010 – 2017
Figure 5–34: Number of Children Being Vaccinated with Polio Vaccines Forecast (in Million),2018 –2025
Figure 5–35: Polio Vaccines Market Value (in Million US$), 2010 – 2017
Figure 5–36: Polio Vaccines Market Value Forecast (in Million US$), 2018 – 2025
Figure 5–37: Rotavirus Vaccines Doses Administered (in Million), 2010–2017
Figure 5–38: Rotavirus Vaccines Doses Administered Forecast (in Million), 2018–2025
Figure 5–39: Number of Children Being Vaccinated with Rotavirus Vaccines (in Million),2010 – 2017
Figure 5–40: Number of Children Being Vaccinated with Rotavirus Vaccines Forecast (in Million),2018 –2025
Figure 5–41: Rotavirus Vaccines Market Value (in Million US$), 2010 – 2017
Figure 5–42: Rotavirus Vaccines Market Value Forecast (in Million US$), 2018 – 2025
Figure 5–43: Hepatitis B Vaccines Doses Administered (in Million), 2010 – 2017
Figure 5–44: Hepatitis B Vaccines Doses Administered Forecast (in Million), 2018 – 2025
Figure 5–45: Number of Children Being Vaccinated with Hepatitis B Vaccines (in Million),2010 – 2017
Figure 5–46: Number of Children Being Vaccinated with Hepatitis B Vaccines Forecast (in Million),2018 – 2025
Figure 5–47: Hepatitis B Vaccines Market Value (in Million US$), 2010 – 2017
Figure 5–48: Hepatitis B Vaccines Market Value Forecast (in Million US$), 2018 – 2025
Figure 5–49: Influenza Pediatric Vaccines Doses Administered (in Million), 2010 – 2017
Figure 5–50: Influenza Pediatric Vaccines Doses Administered Forecast (in Million), 2018 – 2025
Figure 5–51: Number of Children Being Vaccinated with Influenza Pediatric Vaccines (in Million),2010 – 2017
Figure 5–52: Number of Children Being Vaccinated with Influenza Pediatric Vaccines Forecast (in Million),2018 – 2025
Figure 5–53: Influenza Pediatric Vaccines Market Value (in Million US$), 2010 – 2017
Figure 5–54: Influenza Pediatric Vaccines Market Value Forecast (in Million US$), 2018 – 2025
Figure 5–55: MMR Vaccines Doses Administered (in Million), 2010 – 2017
Figure 5–56: MMR Vaccines Doses Administered Forecast (in Million), 2018 – 2025
Figure 5–57: Number of Children Being Vaccinated with MMR Vaccines (in Million),2010 – 2017
Figure 5–58: Number of Children Being Vaccinated with MMR Vaccines Forecast (in Million),2018 – 2025
Figure 5–59: MMR Vaccines Market Value (in Million US$), 2010 – 2017
Figure 5–60: MMR Vaccines Market Value Forecast (in Million US$), 2018 – 2025



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[小児ワクチンのアメリカ市場]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆